Dergiler / Turkish Journal of Gastroenterology / 2020 / Cilt: 31 - Sayı: 10

Determination of B- and T- cell epitopes for Helicobacter pylori cagPAI: An in silico approach

Sayfa
706–712
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Consequently, this in silico analysis should be combined with other pieces of evidence, includ-ing experimental data, to assign function.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims:Helicobacter pylori is classified as a gram-negative bacteria and can cause significant diseases, including gastric cancer, mucosa-associated lymphoid tumor, peptic ulcer, and chronic gastritis.
📊
Temel Bulgular & Veri:Struc-tures of cag Virb11 (Hp0525) and an inhibitory protein (Hp1451) were obtained, and codon optimization and secondary and tertia-ry structure prediction for the cagPAI of H. pylori were analyzed using Garnier-Osguthorpe-Rabson IV secondary structure prediction method and self-optimized prediction method with alignment software.
💡
Sonuç & Katkı:Consequently, this in silico analysis should be combined with other pieces of evidence, includ-ing experimental data, to assign function.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims:Helicobacter pylori is classified as a gram-negative bacteria and can cause significant diseases, including gastric cancer, mucosa-associated lymphoid tumor, peptic ulcer, and chronic gastritis. Recent studies have shown that some autoimmune diseases are also associated with H. pylori. In the past decades, polymorphisms of certain genes of H. pylori, mechanisms and strains of H. pylori, and new therapeutic approaches have continued to be defined. Bioinformatic tools continue to be used in drug design and vaccine design. This study aimed to investigate the cag pathogenicity island (cagPAI) of H. pylori using an in silico approach, which could contribute to vaccine studies.Materials and Methods: The pathogenicity island of H. pylori was obtained from GenBank and analyzed with ClustalW software. Struc-tures of cag Virb11 (Hp0525) and an inhibitory protein (Hp1451) were obtained, and codon optimization and secondary and tertia-ry structure prediction for the cagPAI of H. pylori were analyzed using Garnier-Osguthorpe-Rabson IV secondary structure prediction method and self-optimized prediction method with alignment software. The BcePred prediction server was used to distinguish linear B-cell epitopes, and prediction of T-cell was obtained with NetCTL and MHCPred.Results: According to the physicochemical parameters, the cagPAI of H. pylori was analyzed and found to be stable, and 2 B-cell epi-topes of cagPAI of H. pylori and 2 T-cell epitopes of cagPAI were found in this study.Conclusion: B- and T-cell epitopes that we have identified can induce both humoral and cellular immune responses. Thus, these epi-topes have a potential for vaccine studies. Consequently, this in silico analysis should be combined with other pieces of evidence, includ-ing experimental data, to assign function.

🔖

Bu Makaleye Atıf Yap

TAŞ, S. K., KIRKIK, D., ÖZTÜRK, K., TANOGLU, A. (2020). Determination of B- and T- cell epitopes for Helicobacter pylori cagPAI: An in silico approach. Turkish Journal of Gastroenterology, Cilt: 31 - Sayı: 10, 706–712. https://ajindex.com/articles/408769

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Kekilli M, Onal IK, Ocal S, et al. Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regi-mens as a firstline treatment option for helicobacter pylori. Saudi J Gastroenterol 2016
  2. [Crossref] 2. Ozaydin N,Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sec-tional, screening with the (1)(3)C-Urea breath test. BMC Public Health 2013
  3. [Crossref] 3. Goodwin CS, Armstrong JA, Marshall BJ. Campylobacter pylo-ridis, gastritis, and peptic ulceration. J Clin Pathol 1986
  4. [Crossref] 4. Kusters JG, Vliet AH, Kuipers EJ. Pathogenesis of Helico-bacter pylori infection. Clin Microbiol Rev 2006
  5. [Crossref] 5. Perez-Perez GI, Rothenbacher D, Brenner H. Epidemiology of Heli-cobacter pylori infection. Helicobacter 2004
  6. [Crossref] 6. Smith SM. Role of Toll-like receptors in Helicobacter pylori infec-tion and immunity. World J Gastrointest Pathophysiol 2014
  7. [Crossref] 7. Day AS, Jones JN, Lynett JT, et al. cagE is a virulence factor asso-ciated with Helicobacter pylori-induced duodenal ulceration in chil-dren. J Infect Dis 2000
  8. [Crossref] 8. Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001
  9. [Crossref] 9. Kawahara T, Teshima S, Oka A, et al. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mi-togen oxidase 1 in gastric pit cells. Infect Immun 2001
  10. [Crossref] 10. Mora-Solano C, Collier JH. Engaging adaptive immunity with bio-materials. J Mater Chem B 2014
  11. [Crossref] 11. Potocnakova L, Bhide M, Pulzova LB. An Introduction to B-Cell Epitope Mapping and In Silico Epitope Prediction. J Immunol Res 2016
  12. 6760830. [Crossref] 12. Huleatt JW, Jacobs AR, Tang J et al. Vaccination with recombi-nant fusion proteins incorporating Toll-like receptor ligands induc-es rapid cellular and humoral immunity. Vaccine 2007
  13. [Crossref] 13. Stothard P. The sequence manipulation suite: JavaScript pro-grams for analyzing and formatting protein and DNA sequences. Bio Techniques 2000
  14. [Crossref] 14. Leiro V, Moreno PM, Sarmento B, et al. Bioinspired Materials for Medical Application. 2017
  15. [Crossref] 15. Fitzkee NC, Rose GD. Reassessing random-coil statistics in unfolded proteins. Proc Natl Acad Sci USA 2004
  16. 12497-502. [Crossref] 16. Panc